Home » Topics » Neurology/psychiatric, BioWorld Science

Neurology/psychiatric, BioWorld Science
RSS

Connective Therapeutics commences phase I/II of TCR vaccine for multiple sclerosis

Jan. 13, 1997

MRC scientists investigate role of somatostatin receptors in the CNS

Jan. 13, 1997

French researcher discloses preventive effects of tryptamine derivatives

Jan. 13, 1997

Titan in-licenses antipsychotic drug from HMR

Jan. 10, 1997

New analgesic agent described by Japanese academics

Jan. 10, 1997

Elan/Scherer Zydis formulation license agreement

Jan. 10, 1997

CCD-1042 progresses in trials

Jan. 9, 1997

High-affinity inhibitor of biogenic amine transporters described

Jan. 9, 1997

Pharmacia & Upjohn describes selective 5-HT2 antagonists

Jan. 9, 1997

New analgesic drug candidate emerges from BioChem Pharma/Astra collaboration

Jan. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...